| |
Brief Excerpt: | ...Hospitals' Credit Diagnosis (Promising Early Experience Under Affordable Care Act) (June 2014) Global Pharmaceutical R&D Pipeline (May 2014) U.S. Healthcare Recovery Models ¡ First-Quarter 2014 (May 2014) High-Yield Healthcare Checkup: Comprehensive Analysis of High- Yield U.S. Healthcare Companies (April 2014) Fitch Fundamentals Index -- U.S. Index Trend Analysis 1Q14 (April 2014) U.S. Leveraged Finance Spotlight Series -- HCA Holdings, Inc. (November 2013) For-Profit Hospital Insights (Fitch's Annual Review of Bad Debt Accounting Policies and Practices) (October 2013) Trekking the Path to Biosimilars -- The Destination (October 2013)... |
| |
Report Type: | |
Company(ies) | HCA Inc
, Tenet Healthcare Corporation
, Allergan Finance LLC
, Revvity, Inc
, Universal Health Services, Inc.
, Cardinal Health, Inc.
, Cencora Inc
, Baxter International, Inc.
, McKesson Corp
, Thermo Fisher Scientific Inc.
, Boston Scientific Corporation
, Allergan, Inc.
, CHS/Community Health Systems Inc
, CHS/Community Health Systems Inc
, Abbott Laboratories Inc.
, Bristol-Myers Squibb Company
, Merck & Co., Inc.
, Pfizer Inc.
, Eli Lilly and Company
, Johnson & Johnson |
Ticker(s) | ABC
, ABT
, AGN
, AMGN
, BAX
, BIO
, BMY
, BSX
, CAH
, CFN
, COV
, CYH
, DGX
, ESRX
, HCA
, JNJ
, LLY
, LPNT
, MCK
, MRK |
Issuer | Valeant Pharmaceuticals International Inc. |
Format: | PDF |  |
|
| |